Skip to main content
. 2021 Apr 19;11:664225. doi: 10.3389/fonc.2021.664225

Figure 1.

Figure 1

Schematic illustration of 68Ga-PSMA ligand PET/CT distribution of metastases of oligoprogressive prostate cancer under androgen deprivation therapy prior to radiotherapy (RT) (A) and distrubution of metastases at further progression after PSMA-guided RT (B). Migration of Metastases (C).